Cargando…
CpG plus radiotherapy: a review of preclinical works leading to clinical trial
Studies performed three decades ago in our laboratory supported the hypothesis that radiation efficacy may be augmented by bacterial extracts that stimulate non-specific systemic antitumor immune responses. Application to the clinic was halted by unacceptable side effects and toxicities resulting fr...
Autores principales: | Mason, Kathy A., Hunter, Nancy R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418655/ https://www.ncbi.nlm.nih.gov/pubmed/22912936 http://dx.doi.org/10.3389/fonc.2012.00101 |
Ejemplares similares
-
CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
por: Zhang, Zhongkun, et al.
Publicado: (2021) -
Advances in CpG Island Methylator Phenotype Colorectal Cancer Therapies
por: Zhang, Xiaofei, et al.
Publicado: (2021) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005) -
Factors to preserve CpG-rich sequences in methylated CpG islands
por: Miyahara, Hiroki, et al.
Publicado: (2015)